Drug · DIN 02450550
NATESTO
METERED-DOSE PUMP DELIVERING 5.5MG TESTOSTERONE/ACTUATION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 15, 2022; first marketed May 6, 2016.
- Drug Identification Number (DIN)
- 02450550
- Company (DIN owner)
- Acerus Biopharma IncToronto, Ontario, Canada
- Schedule
- Controlled drugs (CDSA IV)
- Dosage form
- Gel
- Route
- Nasal
- Therapeutic class (ATC)
- Testosterone G03BA03
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TESTOSTERONE | 4.5 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 5, 2016: NOC 17643New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “natesto”. A notice may cover another product or only some lots: read it to see what it covers.
- Natesto Gel (2019-08-07)August 7, 2019 · Drugs · Product safety · Type III